Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|January 4, 2022
Machine learning guided design of high affinity ACE2 decoys for SARS-CoV-2 neutralizationMatthew C Chan, Kui K Chan, Erik Procko, et al.The Journal of Physical Chemistry. B|February 24, 2023
Machine Learning Guided Design of High-Affinity ACE2 Decoys for SARS-CoV-2 NeutralizationMatthew C Chan, Kui K Chan, Erik Procko, et al.Science Advances|February 18, 2021
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variantsKui K Chan, Timothy J C Tan, Krishna K Narayanan, et al.Biorxiv : the Preprint Server for Biology|January 5, 2021
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variantsKui K Chan, Timothy J C Tan, Krishna K Narayanan, et al.Journal of Chemical Information and Modeling|August 24, 2021
Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar AffinityBrandon Havranek, Kui K Chan, Austin Wu, et al.Biochemistry|May 14, 2009
Mechanism of the orotidine 5'-monophosphate decarboxylase-catalyzed reaction: effect of solvent viscosity on kinetic constantsB McKay Wood, Kui K Chan, Tina L Amyes, et al.Biochemistry|August 15, 2008
Structural basis for substrate specificity in phosphate binding (beta/alpha)8-barrels: D-allulose 6-phosphate 3-epimerase from Escherichia coli K-12Kui K Chan, Alexander A Fedorov, Elena V Fedorov, et al.Biochemistry|July 22, 2009
An examination of the relationship between active site loop size and thermodynamic activation parameters for orotidine 5'-monophosphate decarboxylase from mesophilic and thermophilic organismsKrisztina Toth, Tina L Amyes, B McKay Wood, et al.Science (New York, N.Y.)|August 6, 2020
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2Kui K Chan, Danielle Dorosky, Preeti Sharma, et al.Biorxiv : the Preprint Server for Biology|April 5, 2022
An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2Lianghui Zhang, Krishna K Narayanan, Laura Cooper, et al.Pageof 2